STUB1 and neoplasm: While CHIP does carry an increased risk of progression to myeloid neoplasia, this only occurs at a rate of around 1% per year [24], telling us that mutations in genes encoding key components of the methylation machinery may facilitate the development of neoplastic disease, but are clearly not strongly transforming in their own right.